Literature DB >> 12570698

Chromatographic retention parameters in medicinal chemistry and molecular pharmacology.

Antoni Nasal1, Danuta Siluk, Roman Kaliszan.   

Abstract

The importance of lipophilicity for pharmacological and toxicological potency of xenobiotics has been recognized for a century. The reference lipophilicity scale is defined by the logarithm of partition coefficient, log P, determined in the l-octanol-water partition system. The tediousness of determinations and limited interlaboratory reproducibility of log P, on one hand, and the observations of linear relationship between log P and chromatographic retention parameters, on the other hand, gave rise to the substitution of the former by the readily available chromatographic data. Since its introduction, the reversed-phase high - performance liquid chromatography (HPLC), which has been viewed in terms of partition of a solute between a polar, aqueous mobile phase and a nonpolar stationary phase appeared especially suitable for lipophilicity (hydrophobicity) determination. The method got wide acceptance and has officially been recommended by the OECD. Fundamental relationships between chromatographic parameters are reviewed from the point of view of convenient and reliable lipophilicity measurements. The advantages and disadvantages of the stationary phase materials, which are presently employed for the determination of lipophilicity as well as those of specific HPLC systems and procedures, are critically reported. The literature on the application of chromatographic and electrochromatographic methods for assessment of lipophilicity of xenobiotics is reviewed. A separate paragraph is devoted to interpretation of retention parameters from HPLC systems comprising biomacromolecules. Role of lipophilicity in drug-biomacromolecule interactions is discussed in terms of quantitative structure-retention relationships (QSRR). Finally, reports are analyzed on systemic information which can be extracted by multivariate methods of data processing, like principal component analysis (PCA), from sets of lipophilicity parameters determined in diverse HPLC systems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570698     DOI: 10.2174/0929867033368268

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  10 in total

1.  Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling.

Authors:  Paola Gramatica; Ester Papa; Mara Luini; Elena Monti; Marzia B Gariboldi; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-06-06       Impact factor: 3.358

2.  Molecular interaction fields (MIFs) to predict lipophilicity and ADME profile of antitumor Pt(II) complexes.

Authors:  Giulia Caron; Mauro Ravera; Giuseppe Ermondi
Journal:  Pharm Res       Date:  2010-11-17       Impact factor: 4.200

3.  Quantification of Lipophilicity of 1,2,4-Triazoles Using Micellar Chromatography.

Authors:  Małgorzata Janicka; Katarzyna Stępnik; Anna Pachuta-Stec
Journal:  Chromatographia       Date:  2012-04-08       Impact factor: 2.044

4.  A Technical System for the Large-Scale Application of Metabolites From Paecilomyces variotii SJ1 in Agriculture.

Authors:  Qingbin Wang; Chune Peng; Liran Shi; Zhiguang Liu; Dafa Zhou; Hui Meng; Hongling Zhao; Fuchuan Li; Min Zhang
Journal:  Front Bioeng Biotechnol       Date:  2021-05-12

5.  Investigation of Hydro-Lipophilic Properties of N-Alkoxyphenylhydroxynaphthalenecarboxamides †.

Authors:  Iva Kapustikova; Andrzej Bak; Tomas Gonec; Jiri Kos; Violetta Kozik; Josef Jampilek
Journal:  Molecules       Date:  2018-07-04       Impact factor: 4.411

6.  A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.

Authors:  Hristo P Varbanov; Simone Göschl; Petra Heffeter; Sarah Theiner; Alexander Roller; Frank Jensen; Michael A Jakupec; Walter Berger; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2014-07-30       Impact factor: 7.446

7.  A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.

Authors:  Lenka Munoz; Hantamalala Ralay Ranaivo; Saktimayee M Roy; Wenhui Hu; Jeffrey M Craft; Laurie K McNamara; Laura Wing Chico; Linda J Van Eldik; D Martin Watterson
Journal:  J Neuroinflammation       Date:  2007-09-04       Impact factor: 8.322

8.  Investigating biological activity spectrum for novel styrylquinazoline analogues.

Authors:  Josef Jampilek; Robert Musiol; Jacek Finster; Matus Pesko; James Carroll; Katarina Kralova; Marcela Vejsova; Jim O'Mahony; Aidan Coffey; Jiri Dohnal; Jaroslaw Polanski
Journal:  Molecules       Date:  2009-10-23       Impact factor: 4.411

9.  Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids.

Authors:  Jan Dolezel; Petra Hirsova; Veronika Opletalova; Jiri Dohnal; Vejsova Marcela; Jiri Kunes; Josef Jampilek
Journal:  Molecules       Date:  2009-10-20       Impact factor: 4.411

10.  Assessment of Lipophilicity Descriptors of Selected NSAIDs Obtained at Different TLC Stationary Phases.

Authors:  Małgorzata Starek; Alina Plenis; Marta Zagrobelna; Monika Dąbrowska
Journal:  Pharmaceutics       Date:  2021-03-24       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.